Literature DB >> 32557589

How I treat advanced Hodgkin lymphoma - a global view.

Peter Hokland1, Mansi Shah2, Kevin David2, Andrew Evens2, Rebecca Auer3, Rifca Ledieu4, Stefanie Kreissl5, Paul J Bröckelmann5, Peter Borchmann5, Anu Korula6, Vikram Mathews6, Weerapat Owattanapanich7, Judith Trotman8.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32557589      PMCID： PMC7116450          DOI： 10.1111/bjh.16587

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  56 in total

1.  Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.

Authors:  Armando Santoro; Massimo Magagnoli; Michele Spina; Graziella Pinotti; Licia Siracusano; Mariagrazia Michieli; Andrea Nozza; Barbara Sarina; Emanuela Morenghi; Luca Castagna; Umberto Tirelli; Monica Balzarotti
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

2.  (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.

Authors:  Gerard Moulin-Romsee; Elif Hindié; Xavier Cuenca; Pauline Brice; Didier Decaudin; Myriam Bénamor; Josette Brière; Marcela Anitei; Jean-Emmanuel Filmont; David Sibon; Eric de Kerviler; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-04       Impact factor: 9.236

Review 3.  Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease.

Authors:  Ann S LaCasce
Journal:  Hematol Oncol       Date:  2019-06       Impact factor: 5.271

4.  Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma-experience at the Lymph Node Registry Kiel.

Authors:  Alice Johl; Eva Lengfelder; Wolfgang Hiddemann; Wolfram Klapper
Journal:  Ann Hematol       Date:  2016-05-28       Impact factor: 3.673

5.  US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

Authors:  Oliver W Press; Hongli Li; Heiko Schöder; David J Straus; Craig H Moskowitz; Michael LeBlanc; Lisa M Rimsza; Nancy L Bartlett; Andrew M Evens; Erik S Mittra; Ann S LaCasce; John W Sweetenham; Paul M Barr; Michelle A Fanale; Michael V Knopp; Ariela Noy; Eric D Hsi; James R Cook; Mary Jo Lechowicz; Randy D Gascoyne; John P Leonard; Brad S Kahl; Bruce D Cheson; Richard I Fisher; Jonathan W Friedberg
Journal:  J Clin Oncol       Date:  2016-04-11       Impact factor: 44.544

Review 6.  Pulmonary tuberculosis in children with Hodgkin's lymphoma.

Authors:  Zeynep Karakas; Leyla Agaoglu; Baki Taravari; Ebru Saribeyoglu; Ayper Somer; Nermin Guler; Aysegul Unuvar; Sema Anak; Isik Yalcin; Omer Devecioglu
Journal:  Hematol J       Date:  2003

7.  Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.

Authors:  Franck Morschhauser; Pauline Brice; Christophe Fermé; Marine Diviné; Gilles Salles; Reda Bouabdallah; Catherine Sebban; Laurent Voillat; Olivier Casasnovas; Aspasia Stamatoullas; Krimo Bouabdallah; Marc André; Jean-Philippe Jais; Dominique Cazals-Hatem; Christian Gisselbrecht
Journal:  J Clin Oncol       Date:  2008-11-17       Impact factor: 44.544

8.  Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.

Authors:  Patrice Carde; Matthias Karrasch; Catherine Fortpied; Pauline Brice; Hussein Khaled; Olivier Casasnovas; Denis Caillot; Isabelle Gaillard; Serge Bologna; Christophe Ferme; Pieternella Johanna Lugtenburg; Frank Morschhauser; Igor Aurer; Bertrand Coiffier; Ralph Meyer; Matthew Seftel; Max Wolf; Bengt Glimelius; Anna Sureda; Nicolas Mounier
Journal:  J Clin Oncol       Date:  2016-04-25       Impact factor: 44.544

Review 9.  Treatment-Resistant Hodgkin Lymphoma: Defining the Role of Autologous Transplantation.

Authors:  Kristie A Blum
Journal:  Cancer J       Date:  2018 Sep/Oct       Impact factor: 3.360

10.  Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.

Authors:  Abi Vijenthira; Kelvin Chan; Matthew C Cheung; Anca Prica
Journal:  Lancet Haematol       Date:  2020-01-13       Impact factor: 18.959
View more
  1 in total

1.  Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.

Authors:  Andrew M Evens; Susan K Parsons
Journal:  J Clin Oncol       Date:  2020-10-08       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.